Yeji Jeon
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: March 19, 2025
A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models.
Journal: Archives of pharmacal research
Published: March 10, 2025
RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.
Journal: Animal cells and systems
Published: February 11, 2025
N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models.
Journal: Bioscience trends
Published: January 26, 2025
Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways.
Journal: MedComm
Published: October 08, 2024
Serum sEV miRNAs as Biomarkers in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Journal: Molecular neurobiology
Published: September 06, 2024
Neurotoxic Microglial Activation via IFNγ-Induced Nrf2 Reduction Exacerbating Alzheimer's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 29, 2023
Protein L-isoaspartyl methyltransferase regulates p53 activity.
Journal: Nature communications
Published: November 18, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026